# Dewpoint Therapeutics, Inc. — Form D

Dewpoint Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-02. The offering totals $77.1M, of which $77.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-11-02
- Form: D
- Accession: 0001567619-20-018534
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $77.1M
- Amount sold: $77.1M
- Investors: 25
- Date of first sale: 2020-07-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-379484

## Issuer

- Name: Dewpoint Therapeutics, Inc.
- CIK: 0001828893
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 451 D STREET, SUITE 104, BOSTON, MA, 02210
- Phone: 617-914-8448

## Officers, directors & promoters (40)

_Showing 25 of 40 people._

| Name | Role | Location |
| --- | --- | --- |
| Srinivas H Akkaraju, M.D. | Director | Boston, MA |
| Oliver H Brandicourt, M.D. | Director | Boston, MA |
| Giuseeppe H Ciaramella, Ph.D. | Director | Boston, MA |
| Jurgen A Eckhardt, M.D. | Director | Boston, MA |
| Richard A Young, Ph.D. | Director | Boston, MA |
| Bruce H Beutel | Executive Officer | Boston, MA |
| Amir H Nashat | Executive Officer | Boston, MA |
| Regina Barzilay, Ph.D. | Director | Boston, MA |
| Regina Barzilay, Ph.D. | Related Person | Boston, MA |
| Guiseppe A Ciaramella, Ph,D. | Director | Boston, MA |
| Mark A Murcko, Ph.D. | Director | Boston, MA |
| Amir H Nashat, Ph.D. | Director | Boston, MA |
| Olivier Brandicourt, M.D. | Director | Boston, MA |
| Olivier Brandicourt, M.D. | Related Person | Boston, MA |
| Elisabeth A Leiderman | Executive Officer | Boston, MA |
| Ameet Nathwani, M.D. | Director | Boston, MA |
| Ameet Nathwani, M.D. | Executive Officer | Boston, MA |
| Ameet Nathwani, M.D. | Related Person | Boston, MA |
| Isaac A Klein, M.D., Ph.D. | Executive Officer | Boston, MA |
| Srinivas Akkaraju, M.D., Ph.D. | Director | Boston, MA |
| Srinivas Akkaraju, M.D., Ph.D. | Related Person | Boston, MA |
| Lori A Escobedo | Executive Officer | Boston, MA |
| Fabio H Pucci, Ph.D. | Director | Boston, MA |
| Anthony A Hyman, Ph.D. | Director | Boston, MA |
| Giuseppe H Ciaramella, Ph.D. | Director | Boston, MA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2026-07-13](https://search.stillhousedata.com/formd/0001828893-26-000001) | D/A | $82.3M | $77.2M |
| [2025-09-23](https://search.stillhousedata.com/formd/0001828893-25-000002) | D | $59.1M | $59.1M |
| [2022-02-04](https://search.stillhousedata.com/formd/0001567619-22-002514) | D | $150.0M | $150.0M |

## More

- [CIK 1828893 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1828893&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-20-018534.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.